Search details
1.
Decitabine in Older Patients with AML: Quality of Life Results of the EORTC-GIMEMA-GMDS-SG Randomized Phase III Trial.
Blood
; 2024 May 08.
Article
in English
| MEDLINE | ID: mdl-38717861
2.
Gilteritinib in combination with venetoclax, low-dose cytarabine and actinomycin D for relapsed or refractory FLT3-mutated acute myeloid leukaemia.
Br J Haematol
; 204(4): 1227-1231, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38291741
3.
Immunogenicity and clinical effectiveness of mRNA vaccine booster against SARS-CoV-2 Omicron in patients with haematological malignancies: A national prospective cohort study.
Br J Haematol
; 204(2): 497-506, 2024 02.
Article
in English
| MEDLINE | ID: mdl-37786970
4.
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
N Engl J Med
; 384(6): 497-511, 2021 02 11.
Article
in English
| MEDLINE | ID: mdl-33264556
5.
International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
Cancer
; 129(17): 2727-2740, 2023 09 01.
Article
in English
| MEDLINE | ID: mdl-37204189
6.
Impact of body mass index on outcome and treatment-related toxicity in young adults with acute lymphoblastic leukemia.
Acta Oncol
; 62(12): 1723-1731, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37725524
7.
Low incidence of ABL-class and JAK-STAT signaling pathway alterations in uniformly treated pediatric and adult B-cell acute lymphoblastic leukemia patients using MRD risk-directed approach - a population-based study.
BMC Cancer
; 21(1): 326, 2021 Mar 29.
Article
in English
| MEDLINE | ID: mdl-33781217
8.
Glasdegib in combination with low-dose Cytarabine for the outpatient treatment of relapsed or refractory acute myeloid leukemia in unfit patients.
Ann Hematol
; 100(5): 1195-1202, 2021 May.
Article
in English
| MEDLINE | ID: mdl-33661333
9.
Outcomes of relapsed or refractory acute myeloid leukemia patients failing venetoclax-based salvage therapies.
Eur J Haematol
; 106(1): 105-113, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-32997830
10.
Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years.
Blood
; 131(22): 2475-2484, 2018 05 31.
Article
in English
| MEDLINE | ID: mdl-29661787
11.
Prospective validation of the prognostic relevance of CD34+CD38- AML stem cell frequency in the HOVON-SAKK132 trial.
Blood
; 141(21): 2657-2661, 2023 05 25.
Article
in English
| MEDLINE | ID: mdl-36898087
12.
Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin.
Haematologica
; 105(4): 1138-1146, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31413093
13.
Etoposideâ¯+â¯Granulocyte Colony-Stimulating Factor and Optional Plerixafor in Patients Who Failed Chemomobilization with or without Plerixafor.
Biol Blood Marrow Transplant
; 25(7): 1304-1311, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30871977
14.
Oxidative phosphorylation inhibition induces anticancerous changes in therapy-resistant-acute myeloid leukemia patient cells.
Mol Carcinog
; 58(11): 2008-2016, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31385375
15.
Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin.
Am J Hematol
; 94(11): 1236-1243, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31456269
16.
Dose Intensive Rituximab and High-Dose Methylprednisolone in Elderly or Unfit Patients with Relapsed Chronic Lymphocytic Leukemia.
Medicina (Kaunas)
; 55(11)2019 Oct 29.
Article
in English
| MEDLINE | ID: mdl-31671877
17.
Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT.
Br J Haematol
; 182(3): 418-422, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29808926
18.
Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival.
Haematologica
; 108(10): 2794-2798, 2023 10 01.
Article
in English
| MEDLINE | ID: mdl-37021540
19.
Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 65(10): e27300, 2018 10.
Article
in English
| MEDLINE | ID: mdl-29943905
20.
Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria.
Haematologica
; 107(6): 1483-1488, 2022 06 01.
Article
in English
| MEDLINE | ID: mdl-35263983